Loading...

PLRX PLIANT THERAPEUTICS INC Business Restructuring 8-K Filing

PLNT

PLRX

PLIANT THERAPEUTICS INC

(PLRX)

2025 8-K

Management Change

Financial Results Revealed

Executive Departure

Loan Agreement Termination

Financial Statements

Financial Statements

Management Changes

Stockholder Rights

Q4 Financial Results

Q3 Financial Results

Bylaw Amendment

Earnings Report

Positive Clinical Trial Dat...

Board Appointment and Annua...

Clinical Trial Results

Financial Results Announcement

Loan Agreement and Clinical...

Results of Operations and F...

Clinical Trial Results

Financial Results Announcement

Lease Agreement

Positive Clinical Trial Dat...

Financial Results Announcement

Annual Meeting of Stockholders

Financial Results Announcement

Clinical Trial Results

Results of Operations and F...

Board Expansion and New App...

Termination of Collaboratio...

Clinical Trial Results

External Links:

On October 14, 2025, Pliant Therapeutics, Inc. prepaid $32.4 million to terminate a loan agreement, discharging all related obligations. The prepayment cleared their $30 million borrowed under loans exceeding $150 million total available.

AI Assistant

PLIANT THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.